Sideris Pharmaceuticals Investors

17 investors on Angel Roster list Sideris Pharmaceuticals in their portfolio. Most are venture capital firms and private equity firms, the most common stage is Seed and the largest groups are based in the United States.

Investors are matched on the company name in their portfolio, so companies that share the name Sideris Pharmaceuticals can appear together.

Investors listed
17
With verified email
59%
Most common stage
Seed
Top location
United States

Updated October 13, 2026 · How we compile this data

Top 17 Sideris Pharmaceuticals investors

The most complete profiles first. Showing 17 of 17.

  • Ben ScruggsVerified

    Venture Capital, Investor · United States

    SeedHealth CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • Douglas ReedVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 46 more

    Verified email available

  • Jeff TerrellVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • John CrumplerVerified

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 47 more

    Verified email available

  • Brian GoodmanVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Luke EvninVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Michael DialVerified

    Venture Capital · United States

    Health CareWomen FoundedLife ScienceInformation Technology (IT)

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Robert MorffVerified

    Venture Capital, Private Equity Firm · United States

    Health CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Verified email available

  • Shinichiro FuseVerified

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Todd FoleyVerified

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Verified email available

  • Ed Hurwitz

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, Protego Biopharma, InformedDNA, Mitobridge and 60 more

    Contact details available

  • Kseniya Simpson, PhD

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareWomen FoundedAndroidLife Science

    Portfolio: Standard Bariatrics, Contego Medical, Clearside Biomedical, Vigil Neuroscience and 45 more

    Contact details available

  • Stephen Curtis

    Venture Capital, Private Equity Firm, Investor · United States

    SeedHealth CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • William Harrington

    Venture Capital, University Program, Investor · United States

    Series AHealth CareGeneticsPaymentsCybersecurity

    Portfolio: CounterFlow, Infinite Uptime, Modis Therapeutics, Vor Biopharma and 71 more

    Contact details available

  • Christiana Bardon M.D.

    Venture Capital, Private Equity Firm, Investment Partner · United States

    Health CareGeneticsInvestment ManagementLife Science

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Leigh Zawel

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

  • Vinay Bhaskar

    Venture Capital, Private Equity Firm · United States

    Health CareGeneticsLife ScienceInformation Technology (IT)

    Portfolio: CoStim Pharmaceuticals, InformedDNA, Mitobridge, Verastem Oncology and 56 more

    Contact details available

Frequently asked questions

How many Sideris Pharmaceuticals investors are on Angel Roster?

Angel Roster lists 17 Sideris Pharmaceuticals investors. 10 of them (59%) include a verified email address.

What types of investors are they?

The most common investor types are Venture Capital Firms (17), Private Equity Firms (14) and Investment Partner Investors (3). An investor can have more than one type, for example an angel who is also a venture partner.

Which stages do Sideris Pharmaceuticals investors invest in?

Among those that list a stage, the most common are Seed (7) and Series A (1).

Where are Sideris Pharmaceuticals investors based?

Most are based in the United States (17).

Which companies have Sideris Pharmaceuticals investors backed?

The most-backed portfolio companies among them are ReCode Therapeutics (10), Iconic Therapeutics (10), Blade Therapeutics (10), Proteon Therapeutics (9) and CODA Biotherapeutics (9).

How do I contact Sideris Pharmaceuticals investors?

Create a free Angel Roster account to search and filter all 17, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.